N. Coliarakis

726 total citations
8 papers, 549 citations indexed

About

N. Coliarakis is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, N. Coliarakis has authored 8 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Genetics. Recurrent topics in N. Coliarakis's work include Effects of Radiation Exposure (4 papers), Brain Metastases and Treatment (3 papers) and Glioma Diagnosis and Treatment (3 papers). N. Coliarakis is often cited by papers focused on Effects of Radiation Exposure (4 papers), Brain Metastases and Treatment (3 papers) and Glioma Diagnosis and Treatment (3 papers). N. Coliarakis collaborates with scholars based in Greece. N. Coliarakis's co-authors include N. Throuvalas, P. Karageorgis, D. Antonadou, M. Paraskevaidis, George E. Sarris, I. Economou, M. Synodinou, H. Athanassiou, Vasileios Papadopoulos and John Skarlatos and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

N. Coliarakis

8 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Coliarakis Greece 5 427 270 181 172 87 8 549
M. van de Pol Netherlands 12 394 0.9× 136 0.5× 42 0.2× 160 0.9× 111 1.3× 22 527
M. Paraskevaidis Greece 4 326 0.8× 243 0.9× 185 1.0× 65 0.4× 31 0.4× 12 392
Yoshihiko Manabe Japan 14 366 0.9× 89 0.3× 75 0.4× 137 0.8× 222 2.6× 45 501
J. McAleese United Kingdom 15 282 0.7× 95 0.4× 50 0.3× 202 1.2× 132 1.5× 48 478
Irving J. Weigensberg United States 8 248 0.6× 230 0.9× 98 0.5× 65 0.4× 42 0.5× 12 425
C. Barney United States 8 189 0.4× 72 0.3× 130 0.7× 74 0.4× 64 0.7× 22 314
Cem Parlak Türkiye 11 156 0.4× 148 0.5× 49 0.3× 150 0.9× 29 0.3× 30 398
Gudrun Svahn‐Tapper Sweden 11 141 0.3× 51 0.2× 144 0.8× 136 0.8× 89 1.0× 25 509
Michael A. Izard Australia 9 218 0.5× 79 0.3× 30 0.2× 106 0.6× 74 0.9× 19 354
Tuija Wigren Finland 12 235 0.6× 142 0.5× 27 0.1× 117 0.7× 127 1.5× 20 502

Countries citing papers authored by N. Coliarakis

Since Specialization
Citations

This map shows the geographic impact of N. Coliarakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Coliarakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Coliarakis more than expected).

Fields of papers citing papers by N. Coliarakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Coliarakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Coliarakis. The network helps show where N. Coliarakis may publish in the future.

Co-authorship network of co-authors of N. Coliarakis

This figure shows the co-authorship network connecting the top 25 collaborators of N. Coliarakis. A scholar is included among the top collaborators of N. Coliarakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Coliarakis. N. Coliarakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Antonadou, D., N. Coliarakis, Vasileios Papadopoulos, et al.. (2005). A Multicenter, Open Study Evaluating the Impact of Darbepoetin Alfa on Anaemia and Quality of Life, in Cancer Patients Undergoing Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 63. S82–S83. 2 indexed citations
2.
Athanassiou, H., D. Antonadou, N. Coliarakis, et al.. (2003). Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial. International Journal of Radiation Oncology*Biology*Physics. 56(4). 1154–1160. 79 indexed citations
3.
Antonadou, D., N. Coliarakis, M. Paraskevaidis, et al.. (2003). 777 A multi-institutional trial comparing survival of patients with brain metastases from lung cancer treated with temozolomide plus radiotherapy versus radiotherapy alone. European Journal of Cancer Supplements. 1(5). S234–S234. 3 indexed citations
4.
Antonadou, D., N. Coliarakis, M. Paraskevaidis, et al.. (2002). Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III study. International Journal of Radiation Oncology*Biology*Physics. 54(2). 93–94. 37 indexed citations
5.
Antonadou, D., M. Paraskevaidis, George E. Sarris, et al.. (2002). Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases. Journal of Clinical Oncology. 20(17). 3644–3650. 254 indexed citations
6.
Antonadou, D., et al.. (2001). Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer. International Journal of Radiation Oncology*Biology*Physics. 51(4). 915–922. 154 indexed citations
7.
Antonadou, D., et al.. (2001). Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. European Journal of Cancer. 37. S358–S358. 2 indexed citations
8.
Antonadou, D., N. Coliarakis, M. Synodinou, et al.. (1999). 18 Randomized phase III trial of radiation ± amifostine in patients with advanced stage lung cancer. International Journal of Radiation Oncology*Biology*Physics. 45(3). 154–154. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. van de Pol Breakdown of academic impact, for papers by M. Paraskevaidis Breakdown of academic impact, for papers by Yoshihiko Manabe Breakdown of academic impact, for papers by J. McAleese Breakdown of academic impact, for papers by Irving J. Weigensberg Breakdown of academic impact, for papers by C. Barney Breakdown of academic impact, for papers by Cem Parlak Breakdown of academic impact, for papers by Gudrun Svahn‐Tapper Breakdown of academic impact, for papers by Michael A. Izard Breakdown of academic impact, for papers by Tuija Wigren
Rankless by CCL
2026